Immunome (IMNM) Other Working Capital Changes (2019 - 2026)

Immunome's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $6.8 million for Q4 2025.

• Quarterly Other Working Capital Changes rose 176.14% year-over-year to $6.8 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 123.11% YoY) and the FY2025 annual result came in at -$166000.0, up 98.16% from the prior year.
• Other Working Capital Changes was $6.8 million for Q4 2025 at Immunome, up from -$4.0 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $5.7 million in Q4 2023 and bottomed at -$4.0 million in Q1 2022.
• A 5-year average of $397294.1 and a median of -$214000.0 in 2023 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 153633.33% in 2023, while the deepest fall reached 18434.78% in 2023.
• Immunome's Other Working Capital Changes stood at -$157000.0 in 2022, then slumped by 12419.11% to -$19.7 million in 2023, then surged by 54.73% to -$8.9 million in 2024, then jumped by 176.14% to $6.8 million in 2025.
• Business Quant data shows IMNM's Other Working Capital Changes at $6.8 million in Q4 2025, -$4.0 million in Q2 2025, and -$2.9 million in Q1 2025.